Christopher Chan

Christopher Chan currently serves as Executive Director of R&D and holds multiple director-level positions at BioCurate Pty Ltd, with a focus on Protein and Antibody Therapeutics since March 2019. In addition, Christopher Chan acts as Chief Scientific Officer and Director at PIOtx since May 2021. Previous experience includes roles as Senior Scientist II and Senior Scientist in Immuno-oncology at Pionyr Immunotherapeutics from December 2016 to March 2019, and Scientist II and Scientist I at Compugen from September 2014 to December 2016. Christopher Chan began their career as a Postdoctoral Fellow at Oregon Health and Science University from May 2013 to August 2014. Academic credentials include a Ph.D. in Immunology, a Bachelor of Commerce in Economics, and a Bachelor of Science with Honours in Immunology, all from Monash University.